SLC2A1 and endometrial carcinoma: Through our analysis of the TCGA dataset, we discovered that in Uterine Corpus Endometrial Carcinoma (UCEC) samples, the expression level of SLC2A1 was negatively correlated with the expression levels of CD96, CTLA-4, and PDCD-1 (Figures 9A–C).